When the platelet count does not tell the whole story
Dengue in children and young adults can be deceptively reassuring. Young patients may maintain blood pressure, oxygenation and apparently acceptable laboratory parameters despite an evolving systemic inflammatory process. By the time obvious multiorgan dysfunction, shock or disseminated intravascular coagulation (DIC) develops, the therapeutic window may already be narrowing.
This is the story of a 14-year-old girl whose dengue initially gave us very few conventional warning signs—but whose markedly elevated ferritin raised the possibility of evolving dengue-associated hyperinflammation/HLH and changed our approach.
She was known to have bronchial asthma and initially presented with an exacerbation of asthma. She responded to treatment and was discharged, although one symptom persisted: severe headache.
Within 24 hours, she returned with breathlessness and tachycardia. Her oxygen saturation was preserved, and she was treated initially for airway disease. However, her blood gas showed an unexpectedly elevated lactate without an obvious explanation. Dehydration was considered, and the lactate improved after cautious hydration.
Clinically she improved again, but the persistent headache remained unexplained. Importantly, her blood counts at this stage were not particularly alarming.
She was discharged, but approximately 24 hours later she developed high-grade fever for the first time.
Dengue PCR was performed and was positive.
The change in her blood count was dramatic: her platelet count, previously approximately 350,000/µL, had fallen to around 60,000/µL within a short period.
She was immediately readmitted.
Although she remained hemodynamically stable, she appeared unwell and remained tachycardic. Obtaining peripheral venous access and repeated blood sampling became extremely difficult, necessitating ultrasound-guided central venous access with strict sterile precautions. Even this became complicated by bleeding at the neck insertion site and subsequent hematoma formation. Fortunately, the hematoma could be managed conservatively with local compression and close observation and gradually resolved without surgical exploration.
The laboratory result that changed our thinking
We routinely look beyond the platelet count in complicated dengue.
Her serum ferritin was approximately 8,000 ng/mL.
At that point her PT/APTT and the rest of the coagulation profile were relatively preserved. Thus, the platelet count and conventional coagulation parameters alone did not explain the severity of the inflammatory response.
The markedly elevated ferritin, together with her clinical evolution, raised serious concern for dengue-associated hyperinflammation and evolving secondary HLH/macrophage activation syndrome.
Rather than waiting for established multiorgan dysfunction or for every classical diagnostic criterion of HLH to appear, we treated her as a patient at high risk of evolving HLH. Dexamethasone was initiated, while ferritin, LDH, coagulation parameters, blood counts, organ functions and clinical status were followed closely.
Over the following 24 hours, the platelet count fell further to approximately 8,000/µL. She developed extensive rash and menstrual bleeding. Because of clinically significant bleeding with profound thrombocytopenia, platelet support was given. Plasma was also administered in the context of her evolving bleeding risk and the overall clinical picture.
At the same time, fluid management became increasingly important.
She began developing evidence of capillary leak involving the abdomen and pleural spaces, with abdominal discomfort and increasing respiratory difficulty. Fluids were therefore restricted to what was considered necessary for perfusion and maintenance, with frequent reassessment to avoid iatrogenic fluid overload and pulmonary edema/ARDS.
Then came the neurological warning
Her severe headache continued.
By the fourth day she developed three brief episodes of abnormal upward/lateral gaze. CT brain did not demonstrate an acute structural lesion, while EEG was suggestive of encephalopathy. She was managed with anticonvulsant therapy and close neurological monitoring.
This was another reminder that complicated dengue is a multisystem disease, and neurological symptoms should not automatically be dismissed simply because the platelet count, CT scan or hemodynamics appear reassuring.
Fortunately, from approximately the fourth day onward, her clinical trajectory began to improve.
The platelet count recovered progressively. The inflammatory response subsided. Ferritin fell substantially and subsequently normalized. Her hemoglobin, which had fallen from approximately 13 g/dL to 9 g/dL, recovered without red-cell transfusion. The neck hematoma gradually resolved, neurological symptoms settled, and she ultimately made a good recovery.
Why this case matters
The narrow escape in this patient was not because of the platelet count alone.
It was the recognition that the clinical picture was disproportionate to the conventional
laboratory findings.
A young patient can compensate remarkably well until deterioration becomes abrupt. Persistent tachycardia, unexplained lactate elevation, severe headache, capillary leak, bleeding, neurological manifestations and a markedly elevated ferritin should therefore prompt clinicians to look beyond uncomplicated dengue.
Ferritin of 8,000 ng/mL was the major warning signal in this case.
It raised the possibility of an evolving dengue-triggered hyperinflammatory syndrome/secondary HLH before obvious DIC and multiorgan failure had developed. Early recognition allowed intensified monitoring and early treatment of the suspected hyperinflammatory state.
The message I take from this case
Do not manage dengue by watching the platelet count alone.
In patients with concerning clinical features, our practice is to broaden surveillance to include parameters such as ferritin, LDH, coagulation profile including APTT, liver function and markers of evolving organ dysfunction, interpreted together with the patient’s clinical trajectory.
A rapidly rising or markedly elevated ferritin does not by itself establish HLH, and corticosteroids should not be given routinely to patients with uncomplicated dengue. However, striking hyperferritinemia associated with persistent fever, cytopenias, neurological involvement, liver dysfunction, coagulopathy or progressive organ involvement should prompt urgent evaluation for secondary HLH/macrophage activation syndrome and consideration of appropriate treatment based on the complete clinical picture.
This young girl recovered.
But the case left us with an important lesson:
In complicated dengue, deterioration may begin long before shock or multiorgan failure becomes obvious. The opportunity to save a patient lies in recognizing the trajectory— not merely reacting to the platelet count.
Early suspicion. Serial reassessment. Look beyond platelets. Recognize hyperinflammation before irreversible organ failure develops.
